Cargando…
Differential effects of Paclitaxel on dendritic cell function
BACKGROUND: The potential utility of dendritic cells (DC) as cancer vaccines has been established in early trials in human cancers. The concomitant administration of cytotoxic agents and DC vaccines has been previously avoided due to potential immune suppression by chemotherapeutics. Recent studies...
Autores principales: | John, Justin, Ismail, Mohammed, Riley, Catherine, Askham, Jonathan, Morgan, Richard, Melcher, Alan, Pandha, Hardev |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850888/ https://www.ncbi.nlm.nih.gov/pubmed/20302610 http://dx.doi.org/10.1186/1471-2172-11-14 |
Ejemplares similares
-
Activation and Genetic Modification of Human Monocyte-Derived Dendritic Cells using Attenuated Salmonella typhimurium
por: Michael, Agnieszka, et al.
Publicado: (2010) -
The Hitchhiker's Guide to Virotherapy
por: Donnelly, Oliver, et al.
Publicado: (2012) -
Downstream of the HOX genes: Explaining conflicting tumour suppressor and oncogenic functions in cancer
por: Morgan, Richard, et al.
Publicado: (2022) -
PBX3 in Cancer
por: Morgan, Richard, et al.
Publicado: (2020) -
Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances
por: Simpson, Guy R, et al.
Publicado: (2016)